| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 454,4 k € | |||||||||||||||||||
| Gross margin | 169,9 k € | +32.1% | 128,6 k € | +14.4% | 112,5 k € | +27.5% | 88,3 k € | +4.5% | 84,4 k € | +1.2% | 83,4 k € | +33.3% | 62,6 k € | +0.0% | 62,5 k € | -41.9% | 107,6 k € | -0.3% | 108,0 k € | +10.8% | 97,5 k € | +52.0% | 64,1 k € | -17.7% | 77,9 k € | +24.6% | 62,6 k € | +13.2% | 55,3 k € | -2.8% | 56,9 k € | -8.4% | 62,1 k € | +15.8% | 53,7 k € | -7.0% | 57,7 k € | |
| EBITDA | 166,6 k € | +31.7% | 126,5 k € | +14.9% | 110,1 k € | +28.4% | 85,7 k € | +5.1% | 81,6 k € | +1.3% | 80,5 k € | +34.7% | 59,8 k € | +2.3% | 58,4 k € | -44.3% | 105,0 k € | -0.5% | 105,4 k € | +11.1% | 94,9 k € | +54.9% | 61,3 k € | -18.9% | 75,6 k € | +24.3% | 60,8 k € | +15.3% | 52,8 k € | -1.9% | 53,8 k € | -7.4% | 58,1 k € | +15.8% | 50,2 k € | -10.0% | 55,7 k € | |
| Operating profit | 157,4 k € | +32.7% | 118,6 k € | +12.8% | 105,2 k € | +33.1% | 79,0 k € | +12.1% | 70,5 k € | +1.3% | 69,6 k € | +41.9% | 49,0 k € | -3.0% | 50,6 k € | -49.9% | 100,9 k € | +0.6% | 100,3 k € | +14.2% | 87,8 k € | +57.9% | 55,6 k € | -15.4% | 65,7 k € | +25.7% | 52,3 k € | +16.0% | 45,1 k € | -12.9% | 51,8 k € | -8.0% | 56,2 k € | +20.1% | 46,8 k € | -11.4% | 52,9 k € | |
| Profit/loss | 101,5 k € | +33.0% | 76,3 k € | +18.9% | 64,1 k € | +36.6% | 46,9 k € | +20.9% | 38,8 k € | +11.7% | 34,8 k € | +46.9% | 23,7 k € | +26.7% | 18,7 k € | -67.4% | 57,2 k € | -5.4% | 60,5 k € | +11.0% | 54,5 k € | +49.3% | 36,5 k € | -17.6% | 44,3 k € | +20.8% | 36,6 k € | +10.1% | 33,3 k € | -14.5% | 38,9 k € | +38.1% | 28,2 k € | -21.9% | 36,1 k € | -6.3% | 38,6 k € | |
| Equity | 625,7 k € | +19.4% | 524,3 k € | +17.0% | 448,0 k € | +16.7% | 383,9 k € | +13.9% | 337,0 k € | +13.0% | 298,1 k € | +13.2% | 263,4 k € | +9.9% | 239,7 k € | -48.3% | 464,0 k € | +10.2% | 421,1 k € | +16.8% | 360,7 k € | +17.8% | 306,2 k € | -11.2% | 344,7 k € | -1.6% | 350,4 k € | -3.7% | 363,8 k € | -4.4% | 380,5 k € | -2.8% | 391,5 k € | +0.8% | 388,3 k € | -4.4% | 406,2 k € | |
| Total assets | 698,2 k € | +15.6% | 604,2 k € | +13.1% | 534,2 k € | +19.6% | 446,8 k € | +15.3% | 387,4 k € | +11.4% | 347,6 k € | +13.9% | 305,1 k € | -44.5% | 549,9 k € | +5.4% | 521,9 k € | +9.7% | 475,9 k € | +16.5% | 408,6 k € | +3.8% | 393,9 k € | -7.0% | 423,4 k € | -1.5% | 430,1 k € | -2.6% | 441,4 k € | -1.9% | 450,0 k € | +3.3% | 435,9 k € | -0.4% | 437,7 k € | +3.2% | 424,4 k € | |
| Cash | 489,1 k € | +30.4% | 375,1 k € | +7.7% | 348,2 k € | +28.5% | 271,1 k € | +35.9% | 199,5 k € | +48.8% | 134,1 k € | +65.5% | 81,0 k € | -79.0% | 385,5 k € | +1.8% | 378,8 k € | +11.5% | 339,8 k € | +22.4% | 277,7 k € | +1.8% | 272,8 k € | -7.6% | 295,2 k € | +2.2% | 288,7 k € | -1.4% | 292,9 k € | -7.1% | 315,1 k € | +9.3% | 288,2 k € | +5.2% | 273,9 k € | +4.2% | 263,0 k € | |
| Debts | 72,5 k € | -9.3% | 79,9 k € | -7.3% | 86,2 k € | +37.0% | 62,9 k € | +24.8% | 50,4 k € | +1.9% | 49,5 k € | +18.5% | 41,7 k € | -86.5% | 310,2 k € | +435.8% | 57,9 k € | +6.7% | 54,3 k € | +14.0% | 47,6 k € | -45.5% | 87,4 k € | +11.4% | 78,4 k € | -1.6% | 79,7 k € | +3.1% | 77,3 k € | +11.8% | 69,1 k € | +59.6% | 43,3 k € | -1.0% | 43,8 k € | +141.4% | 18,1 k € | |
Private limited company · Châtelet · incorporated on 11/12/1986
Private limited company profitable and well capitalised. Cash position rising (+30.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ESBE - PHARMA is a Private limited company incorporated in 1986. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Châtelet.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette